Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
The following drug companies made headlines this past week.
Here are seven articles published by Becker's Hospital Review this week, detailing two different drug recalls, the top health products recommended by pharmacists in 2017 and more.
Jackson, Tenn.-based Lifeline Blood Services is experiencing a critical shortage of all blood types, reports The Jackson Sun.
Sanofi will invest $673 million annually in biologic drug development over the next two to three years, reports Reuters.
A majority of healthcare C-suite leaders are experiencing increased inpatient pharmacy spending at their hospitals due to high drug costs, according to a new survey from Premier.
The Medical Device and Diagnostic Industry on June 13 announced the 2017 winners of the Medical Design Excellence Awards.
Bristol-Myers Squibb on June 10 recalled more than 48,000 bottles of its blood thinner Eliquis due to dosage issues, reports nj.com.
Takeda Pharmaceuticals will collaborate with Numerate, a computational drug design company, on a new drug development initiative, reports GEN.
The Senate Health, Education, Labor and Pensions Committee on Tuesday held the first of three hearings dedicated to the issue of high drug costs, reports CNBC.
U.S. News & World Report — in collaboration with Pharmacy Times — on Tuesday released its 2017 list of the top health products recommended by pharmacists.